Through the Eyes of the Recipient: Navigating Transfusion Services Amidst COVID-19 in Multi-Transfused Thalassaemic Patients
- PMID: 40224716
- PMCID: PMC11992294
- DOI: 10.1007/s12288-024-01837-4
Through the Eyes of the Recipient: Navigating Transfusion Services Amidst COVID-19 in Multi-Transfused Thalassaemic Patients
Abstract
COVID-19 pandemic led to a decline in voluntary blood donations posing a risk of under-transfusion. This study aimed to evaluate and analyze the root causes of challenges from patients' perspectives, helping blood centers achieve adequate blood supply during pandemics and catastrophes. The questionnaire included 15 questions, 10 of which were option-based. The first part collected demographic data and information on the type of blood component transfused. The second part evaluated the patient's thalassemia status, blood requirements, and how the COVID-19 pandemic impacted their needs. A response was considered valid if 80% of questions were answered. 280 thalassemia patients responded to the questionnaire receiving regular blood transfusions. During the pandemic, 217 patients needed transfusions less than once a month, 33 (12.5%) saw a decrease in transfusion frequency due to fears of infection, lack of transportation, and reduced needs. However, 7 (2.65%) saw an increase in transfusion frequency. The waiting time for blood also increased for 63.88% patients, by less than two hours for most. COVID-19 pandemic has significantly impacted thalassemia patients' routine activities, with only 12.5% of patients experiencing reduced transfusion visits due to fear of infection and limited transportation services. Blood donations decreased, but reduced elective surgeries helped balance out. Workforce shortages at blood centers and pandemic management diversions caused delays for some patients. Looking into the past catastrophe from the perspective of the sufferers, especially in thalassemia patients, will enable the policy makers to prepare an organogram to intercept any such future setback.
Keywords: Blood bank; Covid19; Impact; Pandemic; Thalassemia; Transfusion.
© Indian Society of Hematology and Blood Transfusion 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestTo the best of my knowledge, I declare that none of the authors have any significant competing financial, professional, or personal interests that could have influenced the design, conduct, analysis, interpretation, or presentation of the research reported in this manuscript.
Similar articles
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Service Interruption in HIV Care Amid COVID-19 Pandemic in Myanmar: Results From Analysis of Routine Program Data 2018-2022.J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241299466. doi: 10.1177/23259582241299466. J Int Assoc Provid AIDS Care. 2024. PMID: 39648608 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
References
-
- Burden of thalassemia in India: The road map for control Roshan Colah*, Khushnooma Italia, AjitGorakshaka
-
- Oymak Y, Karapinar TH (2021) COVID-19 Pandemic and thalassemia major patients: transfusion practice and treatment assessment. J Pediatr Hematol Oncol 43(8):e1073–e1076. 10.1097/MPH.0000000000002016. (PMID: 33273415) - PubMed
-
- The COVID–19 pandemic and haemoglobin disorders a contribution of Thalassaemia international federation to its global patients’ community version II
LinkOut - more resources
Miscellaneous